Effective Control of Supraventricular Tachycardia in Neonates May Requires Combination Pharmacologic Therapy.

Since most neonatal SVT resolves within 1 year, it is significant to provide prophylactic medication to prevent tachycardia recurrence at least until 1 year of age, and depending on the patient, the appropriate combination of medications should be identified.